KRT15 anticorps (AA 101-200) (Cy3)
Aperçu rapide pour KRT15 anticorps (AA 101-200) (Cy3) (ABIN2177141)
Antigène
Voir toutes KRT15 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 101-200
-
Homologie
- Human,Mouse,Rat,Dog,Horse
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human KIF15
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- KRT15 (Keratin 15 (KRT15))
-
Autre désignation
- K15
-
Sujet
-
Synonyms: Kinesin like protein 7, KLP2, FLJ25667, HKLP2, Kinesin family member 15, Kinesin like protein 2, Kinesin like protein 7, Kinesin like protein K15, KLP2, KNSL7, Linesin like 7, NY BR 62, NYBR62, Serologically defined breast cancer antigen NY BR 62, Serologically defined breast cancer antigen NYBR62, FLJ25667, K15_HUMAN.
Background: KIF15 belongs to the kinesin-like protein family and contains 1 kinesin-motor domain. KIF15 is the plus-end directed kinesin-like motor enzyme involved in mitotic spindle assembly.
-
ID gène
- 56992
Antigène
-